KUALA LUMPUR (Reuters) – Malaysian health authorities said on Friday conditional approval had been granted for AstraZeneca’s COVID-19 vaccine manufactured by Siam Bioscience Co in Thailand.
Health Ministry director-general, Noor Hisham Abdullah, said in a statement the vaccine supply received from Thailand is expected to speed up implementation of Malaysia’s national vaccination programme.
(Reporting by Joseph Sipalan; Editing by Ed Davies)
